
Overview
Dr. Christopher K. Lippincott is an infectious diseases specialist at the Johns Hopkins University School of Medicine. He is the Clinical Director for the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis. He is an expert in the care of patients with mycobacterial infections (NTM and tuberculosis), HIV/AIDS, Lyme disease, and general infectious diseases. He provides teaching to medical students, residents and fellows at the Johns Hopkins University School of Medicine. Dr. Lippincott earned his M.D. at the University of Virginia School of Medicine. He completed his residency at The Ohio State University Wexner Medical Center and infectious diseases fellowship at the University of North Carolina Hospitals. He also earned a Master of Public Health in epidemiology from the University of North Carolina at Chapel Hill in 2013. Prior to joining Johns Hopkins University in 2015, Dr. Lippincott practiced infectious diseases internationally for Medecins Sans Frontieres (Abkhazia, Georgia) and Right to Care (Johannesburg, South Africa). Dr. Lippincott’s research interests include mycobacterial infections (NTM and tuberculosis) and bronchiectasis.
Dr. Lippincott is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Swimming Pool Granuloma, Nontuberculous Mycobacterial Lung Disease, Osteomyelitis, and Osteomyelitis in Children.
Dr. Lippincott is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 1 clinical trial. Dr. Lippincott is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5501 Hopkins Bayview Circle, Allergy & Asthma Center, 2nd Floor, Baltimore, MD 21224
1717 East Monument Street, Park Building, Ground Level, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
The Johns Hopkins Hospital
Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever. Dr. Durbin is board certified in American Board Of Internal Medicine. Dr. Durbin is currently accepting new patients.
The Johns Hopkins Hospital
Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Gonorrhea, Cryptococcosis, Syphilis, and Tissue Biopsy. Dr. Manabe is currently accepting new patients.
Dr. Thomas Quinn is professor of medicine and pathology in the Johns Hopkins School of Medicine and professor of international health, epidemiology, and molecular microbiology and immunology in The Johns Hopkins School of Public Health, and professor of nursing in the Johns Hopkins School of Nursing. In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health. He serves as advisor/consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the American Association for the Advancement of Science. He is a fellow of the Infectious Diseases Society of America and a member of the American Association of Physicians. He is an author of over 900 publications on HIV, STDs, and infectious diseases, and serves on multiple editorial boards. Among his professional activities, Dr. Quinn is an alternate member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been on Advisor/Consultant on HIV and STDs to the World Health Organization, UNAIDS, and the U.S. Food and Drug Administration. In October 2004 he received membership in the Institute of Medicine. Dr. Quinn is highly rated in 13 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Genital Herpes, Chlamydia, and Human Papillomavirus Infection. Dr. Quinn is board certified in American Board Of Internal Medicine. Dr. Quinn is currently accepting new patients.
The Johns Hopkins Hospital
Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Gebo is board certified in American Board Of Internal Medicine. Dr. Gebo is currently accepting new patients.
Johns Hopkins Hospital
Mark Tenforde is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Tenforde is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Meningitis, Cryptococcosis, Flu, Severe Acute Respiratory Syndrome (SARS), and Spinal Fusion.
The Johns Hopkins Hospital
John Baddley is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Baddley is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia. Dr. Baddley is board certified in American Board Of Internal Medicine. Dr. Baddley is currently accepting new patients.
Frequently Asked Questions about Dr. Christopher K. Lippincott
How do I make an appointment with Dr. Christopher K. Lippincott?
You can book an appointment with Dr. Christopher K. Lippincott by calling their office at 410-550-5864. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Christopher K. Lippincott a top-rated expert for Swimming Pool Granuloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christopher K. Lippincott is classified as an Distinguished expert for Swimming Pool Granuloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Christopher K. Lippincott specialize in?
While Dr. Christopher K. Lippincott is a Infectious Disease, they have specific expertise in Swimming Pool Granuloma, Nontuberculous Mycobacterial Lung Disease, and Osteomyelitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.
Does Dr. Christopher K. Lippincott participate in research or clinical trials?
Yes. Dr. Christopher K. Lippincott has published 24 articles and abstracts on conditions like Swimming Pool Granuloma. You can view a list of Dr. Christopher K. Lippincott's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Christopher K. Lippincott accept my insurance?
Dr. Christopher K. Lippincott accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-550-5864 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Nontuberculous Mycobacterial Lung DiseaseDr. Lippincott isDistinguished. Learn about Nontuberculous Mycobacterial Lung Disease.
- Swimming Pool GranulomaDr. Lippincott isDistinguished. Learn about Swimming Pool Granuloma.
- Experienced
- AIDS Dementia ComplexDr. Lippincott isExperienced. Learn about AIDS Dementia Complex.
- AIDS Dysmorphic SyndromeDr. Lippincott isExperienced. Learn about AIDS Dysmorphic Syndrome.
- Allergic Bronchopulmonary AspergillosisDr. Lippincott isExperienced. Learn about Allergic Bronchopulmonary Aspergillosis.
- EndocarditisDr. Lippincott isExperienced. Learn about Endocarditis.
- HIV/AIDSDr. Lippincott isExperienced. Learn about HIV/AIDS.
- Infective EndocarditisDr. Lippincott isExperienced. Learn about Infective Endocarditis.
- MeningitisDr. Lippincott isExperienced. Learn about Meningitis.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)
- MyelitisDr. Lippincott isExperienced. Learn about Myelitis.
- NeurosyphilisDr. Lippincott isExperienced. Learn about Neurosyphilis.
- NocardiosisDr. Lippincott isExperienced. Learn about Nocardiosis.
- OsteomyelitisDr. Lippincott isExperienced. Learn about Osteomyelitis.
- Osteomyelitis in ChildrenDr. Lippincott isExperienced. Learn about Osteomyelitis in Children.
- Strep ThroatDr. Lippincott isExperienced. Learn about Strep Throat.
- Streptococcal Group B InfectionDr. Lippincott isExperienced. Learn about Streptococcal Group B Infection.



